C07D 295/182
Radicals derived from carboxylic acids
C07D295/182 (Radicals derived from carboxylic acids) appears on 2,400 US grants and 1,892 published applications in this corpus.
Search patents in C07D- Granted patents
- 2,400
- Published applications
- 1,892
- Assignees
- 1,072
- Inventors
- 7,171
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 17 | 0 |
| 1977 | 36 | 0 |
| 1978 | 46 | 0 |
| 1979 | 40 | 0 |
| 1980 | 28 | 0 |
| 1981 | 36 | 0 |
| 1982 | 29 | 0 |
| 1983 | 23 | 0 |
| 1984 | 31 | 0 |
| 1985 | 32 | 0 |
| 1986 | 27 | 0 |
| 1987 | 27 | 0 |
| 1988 | 38 | 0 |
| 1989 | 42 | 0 |
| 1990 | 45 | 0 |
| 1991 | 38 | 0 |
| 1992 | 34 | 0 |
| 1993 | 42 | 0 |
| 1994 | 41 | 0 |
| 1995 | 52 | 0 |
| 1996 | 36 | 0 |
| 1997 | 59 | 0 |
| 1998 | 64 | 0 |
| 1999 | 60 | 0 |
| 2000 | 50 | 0 |
| 2001 | 55 | 24 |
| 2002 | 78 | 78 |
| 2003 | 72 | 117 |
| 2004 | 52 | 122 |
| 2005 | 65 | 120 |
| 2006 | 66 | 95 |
| 2007 | 68 | 106 |
| 2008 | 52 | 95 |
| 2009 | 60 | 89 |
| 2010 | 70 | 94 |
| 2011 | 59 | 57 |
| 2012 | 72 | 76 |
| 2013 | 55 | 60 |
| 2014 | 59 | 83 |
| 2015 | 64 | 81 |
| 2016 | 82 | 83 |
| 2017 | 73 | 68 |
| 2018 | 39 | 56 |
| 2019 | 43 | 57 |
| 2020 | 38 | 54 |
| 2021 | 42 | 62 |
| 2022 | 42 | 58 |
| 2023 | 27 | 49 |
| 2024 | 32 | 44 |
| 2025 | 42 | 35 |
| 2026 | 20 | 29 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- NAMPT modulators29 Sep 2026US 12,747,203 B2Cytokinetics, Inc.
- Alpha-carbonyl alkenyl ester preparation method therefor and application thereof15 Sep 2026US 12,735,449 B2Jiangxi Normal University
- Low toxicity NMP substitutes and uses thereof25 Aug 2026US 12,715,850 B2Advancion Corporation
- Ferroptosis inhibitors—diarylamine para-acetamides25 Aug 2026US 12,715,855 B2Sironax Ltd.
- Sulfone compounds and pharmaceutical compositions thereof, and their therapeutic applications11 Aug 2026US 12,703,679 B2Cura Therapeutics, LLC
- Heterocycloalkyl beta-hydroxy alkyl amines for use in the treatment of hyperglycaemia and disorders characterised by hyperglycaemia20 Aug 2026US 2026/0242335 A1Atrogi AB
- Regio-controllable [2+2] benzannulation with two adjacent c(sp3)-h bonds20 Aug 2026US 2026/0242341 A1The Scripps Research Institute
- Inhibitors of the ras oncoprotein, methods of making and methods of use thereof13 Aug 2026US 2026/0232689 A1University of Louisville Research Foundation, Inc.
- Bifunctional molecules for targeted protein degradation13 Aug 2026US 2026/0232812 A1
- Therapeutic compounds and compositions13 Aug 2026US 2026/0234110 A1Agios Pharmaceuticals, Inc.
Most cited
By later US patents
- Photoresist monomers, polymers thereof, and photoresist compositions containing the same470US 6,607,868 B2Hynix Semiconductor Inc. · 2003
- Stilbene derivatives222US 4,326,055 AHoffmann-La Roche Inc. · 1982
- Arylsulfonylamino hydroxamic acid derivatives213US 5,863,949 APfizer Inc. · 1999
- Inhibitors of farnesyl-protein transferase204US 5,856,326 AMerck & Co., Inc. · 1999
- Retroviral protease inhibiting compounds159US 5,142,056 AAbbott Laboratories · 1992